Metopio Secures Growth Investment to Expand Data-Driven Solutions for Community Health

Associated Press

07-04-2025

Metopio has secured a multi-million-dollar investment led by Plymouth Growth, that promises to transform how organizations uncover, understand, and act on critical community insights. This strategic funding marks a pivotal moment in broadening access to data, empowering healthcare and public health professionals to make faster, more informed decisions that directly impact community well-being.
Metopio is not just another data platform—it's a community intelligence solution trusted by over 475 hospitals and public health departments, serving geographies representing more than 20 million people. By providing instant access to thousands of datasets covering every corner of the United States with built-in analytics and report generation, the company is breaking down the complex barriers that have traditionally prevented organizations from leveraging their most powerful resource: comprehensive, actionable data.
'Every dataset represents real lives, real communities, and real opportunities to drive meaningful change,' said Will Snyder, CEO and Co-Founder of Metopio. 'We know that healthcare leaders need to dig deep into the root causes of health conditions and our technology provides those insights at the speed of need. This investment isn't just about technology—it's about giving healthcare and public health professionals the tools to transform complex information into immediate, life-improving actions.'
The platform's AI-integrated approach dramatically simplifies critical processes like Community Health Needs Assessments (CHNAs) and Community Health Improvement Plans (CHIPs). By automating tedious manual tasks, Metopio is freeing up professionals to focus on what truly matters: developing targeted interventions and strategies that can significantly improve health outcomes.
Kathleen Kaulins, Investor at Plymouth Growth, sees Metopio as a catalyst for systemic change within healthcare. 'We understand that data can be overwhelming which is why Metopio stands out,' she explained. 'The platform is not just providing information—Metopio is a purpose-built data analytics tool that enables organizations to respond to pressing health challenges with unprecedented speed, precision, and confidence.'
The newly secured capital will fuel an ambitious product roadmap, team expansion, and enhanced support capabilities. Metopio is poised to further its commitment to transforming how organizations harness data, with a clear vision of making valuable data and advanced analytics available to any user, regardless of their data training.
As healthcare continues to evolve, Metopio is proving that purpose-built technology for community intelligence can not only improve operations but health outcomes.
About Metopio
Metopio provides powerful data analytics and visualization tools to help public and private sector leaders make informed decisions that drive community progress. With a focus on accessibility and ease of use, Metopio empowers organizations to transform complex data into meaningful insights. Its platform features automated CHA & CHIP workflows, instant community trend analysis, interactive maps, customizable dashboards, and intuitive report generation—helping public health leaders work smarter, faster, and more effectively. Based in Chicago, IL, Metopio is committed to fostering collaboration and improving public health outcomes. metopio.com.
About Plymouth Growth
Plymouth Growth invests in mid-continent B2B software and technology companies – with proven business models, rapid growth, and strong teams – that are ready to scale. The Plymouth team brings decades of experience as operators, advisors, and investors and understands that while metrics matter, it's people who are critical to growth. Based in Ann Arbor, MI, and actively investing out of its fifth fund, Plymouth Growth helps teams achieve smart, proven growth. www.plymouthgp.com.
SOURCE: Metopio
Copyright Business Wire 2025.
PUB: 04/07/2025 08:05 AM/DISC: 04/07/2025 08:05 AM